Trinity Biotech (TRIB) Enterprise Value (2016 - 2024)
Trinity Biotech (TRIB) has disclosed Enterprise Value for 9 consecutive years, with -$5.2 million as the latest value for Q4 2024.
- Quarterly Enterprise Value fell 39.99% to -$5.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$5.2 million through Dec 2024, down 39.99% year-over-year, with the annual reading at -$5.2 million for FY2024, 39.99% down from the prior year.
- Enterprise Value hit -$5.2 million in Q4 2024 for Trinity Biotech, down from -$3.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$3.7 million in Q4 2023 to a low of -$27.3 million in Q4 2020.
- Historically, Enterprise Value has averaged -$13.7 million across 5 years, with a median of -$6.6 million in 2022.
- Biggest five-year swings in Enterprise Value: tumbled 55.54% in 2020 and later soared 74.61% in 2022.
- Year by year, Enterprise Value stood at -$27.3 million in 2020, then grew by 5.19% to -$25.9 million in 2021, then skyrocketed by 74.61% to -$6.6 million in 2022, then skyrocketed by 43.89% to -$3.7 million in 2023, then plummeted by 39.99% to -$5.2 million in 2024.
- Business Quant data shows Enterprise Value for TRIB at -$5.2 million in Q4 2024, -$3.7 million in Q4 2023, and -$6.6 million in Q4 2022.